Preparing student pharmacists to identify opioid misuse, prevent overdose and prescribe naloxone

U.S. Department of Health and Human Services Bailey, 2014, Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings, Ann Pharmacother, 48, 601, 10.1177/1060028014523730 American Pharmacists Association American Society of Health-System Pharmacists, 2014, ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance, Am J Health Syst Pharm, 71, 243, 10.2146/sp140002 National Alliance of State Pharmacy Associations Roberts, 2018, Reviewing state-mandated training requirements for naloxone-dispensing pharmacists, Res Soc Adm Pharm Schartel, 2018, Implementation and assessment of a naloxone-training program for first-year student pharmacists, Curr Pharm Teach Learn, 10, 717, 10.1016/j.cptl.2018.03.016 Hines, 2018, Student pharmacist perceptions of participation in hands-on naloxone counseling, Curr Pharm Teach Learn, 10, 712, 10.1016/j.cptl.2018.03.002 Freeman, 2017, Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing, J Am Pharm Assoc (2003), 57, S28, 10.1016/j.japh.2016.12.064 House of Delegates Sessions, 2016, July 24–27, Anaheim, California, Am J Pharm Educ, 80 Medina, 2013, Center for the advancement of pharmacy education 2013 educational outcomes, Am J Pharm Educ, 77, 10.5688/ajpe778162 Maguire, 2018, A naloxone and harm reduction educational program across four years of a doctor of pharmacy program, Curr Pharm Teach Learn, 10, 72, 10.1016/j.cptl.2017.09.007 Donohoe, 2018, Preparing pharmacy students to manage the opioid crisis, Am J Pharm Educ Jacobson, 2018, Retention of student pharmacists' knowledge and skills regarding overdose management with naloxone, Subst Abus, 39, 193, 10.1080/08897077.2018.1439797 CE Online OpiSafe, Inc Centers for Disease Control and Prevention Substance Abuse and Mental Health Services Administration U.S. Department of Justice North Dakota Board of Pharmacy Webster, 2005, Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool, Pain Med, 6, 432, 10.1111/j.1526-4637.2005.00072.x Crawford Prescribe to Prevent Institute of Medicine, 1990 Armonk, NY: IBM Corp, 2017